Hyperplastic osteoarthropathy
Clinically, hyperplastic osteoarthritis can have multiple names, including degenerative arthritis, osteoarthritis and hypertrophic arthritis, etc. This disease is a chronic joint disease caused by joint degeneration, resulting in the destruction of articular cartilage.
-
Site of disease:
Whole body bones -
Infectious :
Not contagious -
Frequent population:
Middle-aged and elderly people over 50 years old -
Related symptoms:
Joint swelling Joint pain Deepening of forehead lines Joint ankylosis Persistent pain -
Concurrent disease:
Related Drugs
Bone spur pain relief tablets
Manufacturer:
Xiangxue Pharmaceutical Co., Ltd.
Meloxicam Tablets
Indication: 1. Short-term symptomatic treatment of osteoarthritis symptoms. 2. Long-term symptomatic treatment of rheumatoid arthritis and ankylosing spondylitis.
Compound Psoralea corylifolia Granules
Manufacturer:
Shanghai Lei Yun Shang Pharmaceutical Co., Ltd.
Etodolac Tablets
Indication: (1) Osteoarthritis (degenerative joint disease). (2) Rheumatoid arthritis. (3) Pain symptoms This product can be used to treat acute attacks of the above diseases, and can also be used for long-term treatment of the above diseases.
Manufacturer:
Guangzhou Nucien Pharmaceutical Co., Ltd.
Anti-bone hyperplasia capsule
Manufacturer:
Jiangsu Kanion Pharmaceutical Co., Ltd.
Imidazole Salicylate Tablets
Indication: This product is suitable for joint pain, swelling and fever caused by rheumatoid arthritis, osteoarthritis and other rheumatic diseases
Manufacturer:
Jilin Aodong--Taonan Pharnalentical Company Ltd
Related Ingredients
-
Meloxicam list
71125-38-7 -
Psoralen list
66-97-7 -
Etodolac list
41340-25-4